Program overview
Context
Indication: Sarcoma
Mechanism: Unknown
Modality: Unknown
Sponsor: Gynecologic Oncology Group
Registry Stop Signal
sargramostim
sargramostim is flagged as registry stop signal because public records show a registry stop signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 5/5
Timeline: 1/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 3/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT00033644 | https://clinicaltrials.gov/study/NCT00266110
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT00033644 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | None |
| NCT00266110 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | None |